4/16
05:30 pm
glue
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Medium
Report
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
4/1
06:09 am
glue
Form EFFECT Monte Rosa Therapeutics,
Medium
Report
Form EFFECT Monte Rosa Therapeutics,
3/25
06:32 pm
glue
Form 4 Monte Rosa Therapeutics, For: Mar 24 Filed by: Leo Chandra P.
Medium
Report
Form 4 Monte Rosa Therapeutics, For: Mar 24 Filed by: Leo Chandra P.
3/20
09:37 am
glue
Form S-3 Monte Rosa Therapeutics,
Medium
Report
Form S-3 Monte Rosa Therapeutics,
3/20
09:13 am
glue
Form S-8 Monte Rosa Therapeutics,
Medium
Report
Form S-8 Monte Rosa Therapeutics,
3/20
09:05 am
glue
Form 10-K Monte Rosa Therapeutics, For: Dec 31
Medium
Report
Form 10-K Monte Rosa Therapeutics, For: Dec 31
3/20
07:04 am
glue
Form 8-K Monte Rosa Therapeutics, For: Mar 20
Low
Report
Form 8-K Monte Rosa Therapeutics, For: Mar 20
2/14
09:30 am
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Avoro Capital Advisors LLC
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Avoro Capital Advisors LLC
2/4
03:46 pm
glue
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: BlackRock, Inc.
1/31
06:43 pm
glue
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Medium
Report
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
1/30
09:59 pm
glue
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: VANGUARD GROUP INC